WORLD DISTRIBUTION OF FACTOR V LEIDEN MUTATION

No abstract is available for this paper.

• Publication year

  1996

• Venue

  The Lancet

• Publication date

  1996-01-06

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/S0140-6736(96)91590-1
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• Single Point Mutation at Arg506 of Factor V Associated with APC Resistance and Venous Thromboembolism: Improved Detection by PCR-Mediated Site-Directed Mutagenesis

  1995cited by this paper
• Mutation in the gene coding for coagulation factor V and the risk of myocardial infarction, stroke, and venous thrombosis in apparently healthy men.

  1995cited by this paper
• High risk of thrombosis in patients homozygous for factor V Leiden (activated protein C resistance)

  1995cited by this paper
• Variability of Thrombosis among Homozygous Siblings with Resistance to Activated Protein C Due to an Arg-to-Gln Mutation in the Gene for Factor V

  1994cited by this paper
• Mutation in blood coagulation factor V associated with resistance to activated protein C

  1994cited by this paper
• Physiological anticoagulation. Resistance to activated protein C and venous thromboembolism.

  1994cited by this paper
• Factor V Leiden--an unselfish gene?

  1994cited by this paper
• Asian Indian HLA-DR2-, DR4-, and DR52-related DR-DQ genotypes analyzed by polymerase chain reaction based nonradioactive oligonucleotide typing. Unique haplotypes and a novel DR4 subtype.

  1994cited by this paper
• Venous thrombosis due to poor anticoagulant response to activated protein C: Leiden Thrombophilia Study.

  1993cited by this paper
• Detecting single base substitutions as heteroduplex polymorphisms.

  1992cited by this paper
• Lipoprotein profile of a Greenland Inuit population. Influence of anthropometric variables, Apo E and A4 polymorphism, and lifestyle.

  1992cited by this paper
• Mortality from ischaemic heart disease and cerebrovascular disease in Greenland.

  1988cited by this paper

• Changes in Biomarkers of Coagulation, Fibrinolytic, and Endothelial Functions for Evaluating the Predisposition to Venous Thromboembolism in Patients With Hereditary Thrombophilia

  2020cites this paper
• Clinical characteristics, risk factors, and outcomes of usual and unusual site venous thromboembolism

  2018cites this paper
• Risk factors in childhood arterial ischaemic stroke: Findings from a population-based study in Germany.

  2018cites this paper
• Review article: the aetiology of primary Budd–Chiari syndrome – differences between the West and China

  2016cites this paper
• Factor V Leiden Mutation and Color of Skin in Arabs

  2015cites this paper
• Fausses couches précoces « à répétition » : bilan et prise en charge

  2014cites this paper
• Evolution of Factor V Leiden

  2013cites this paper
• V.-jugularis-Thrombose bei Hyperkoagulabilität nach In-vitro-Fertilisation

  2013cites this paper
• Aetiology of Venous Thrombosis

  2012cites this paper
• Thrombosis risk in carriers of the factor V Leiden mutation: is it associated with a defined skin color?

  2011cites this paper
• Mediterranean Journal of Hematology and Infectious Diseases Epidemiology of Activated Protein C Resistance the Mediterranean Region

  2011cites this paper
• Race differences in the prevalence of the factor V Leiden mutation in Kuwaiti nationals

  2011cites this paper
• Introduction to haemostasis from a pharmacodynamic perspective.

  2011cites this paper
• Genetic aspects of ischemic stroke: coagulation, homocysteine, and lipoprotein metabolism as potential risk factors

  2010cites this paper
• Factor V Leiden mutation in Arabs in Kuwait by real-time PCR: different values for different Arabs

  2010cites this paper
• High Prevalence of Activated Protein C Resistance and Factor V Leiden Mutation in an Arab Population and Patients With Venous Thrombosis in Kuwait

  2010cites this paper
• Genetic Thrombophilia Variants and Risk for Preeclampsia Among American Indians

  2009cites this paper
• Portal, splenic and mesenteric vein thrombosis in a patient double heterozygous for factor V Leiden and prothrombin G20210A mutation.

  2009cites this paper
• Acute myocardial infarction, ischemic cerebrovascular disease and variceal bleeding due to portal vein thrombosis in a patient with hereditary thrombophilia.

  2008cites this paper
• Activations of coagulation and fibrinolysis secondary to bowel inflammation in patients with ulcerative colitis.

  2007cites this paper
• Fisiopatología de la trombosis

  2007cites this paper
• Comment on ‘cosegregation of two unlinked mutant alleles in some cases of autosomal dominant familial exudative vitreoretinopathy’

  2006cites this paper
• Guías para el Diagnóstico, Prevención y Tratamiento de la Enfermedad Tromboembólica Venosa

  2006cites this paper
• Reply to Bottomley et al

  2006cites this paper
• The Basques: Review of Population Genetics and Mendelian Disorders

  2005cites this paper
• Varied Prevalence of Factor V G1691A (Leiden) and Prothrombin G20210A Single Nucleotide Polymorphisms Among Arabs

  2005cites this paper
• Thrombophilic conditions in non-cirrhotic portal vein thrombosis.

  2005cites this paper
• Thrombophilias and gynaecology.

  2003cites this paper
• Genotype distribution of the mutations in the coagulation factor V gene in the Korean population: Absence of its association with coronary artery disease

  2003cites this paper
• Population genetics of factor V Leiden in Europe.

  2001cites this paper
• Genetic aspects of the hemostatic system in cerebrovascular disease

  2001cites this paper
• Venous Thromboembolism in Young Patients From Western India: A Study

  2001cites this paper
• High prevalence of factor V mutation (Leiden) in the Eastern Mediterranean.

  2000cites this paper
• Comparison of the Risk of Pulmonary Embolism and Deep Vein Thrombosis in the Presence of Factor V Leiden or Prothrombin G20210A

  2000cites this paper
• The prevalence of factor V R506Q mutation‐Leiden among apparently healthy Lebanese

  2000cites this paper
• DNA technology for the detection of common genetic variants that predispose to thrombophilia

  2000cites this paper
• Thrombophilic Mutations in Iran

  2000cites this paper
• Screening for thrombophilic risk factors among 25 German patients with cerebral venous thrombosis

  2000cites this paper
• Proficiency Testing of Therapeutic Drug Monitoring Techniques

  1999cites this paper
• The Incidence of Factor V Leiden in a Normal Irish Population and Its Relationship to the Laboratory Diagnosis of APC Resistance

  1999cites this paper
• DNA-Polymorphisms and Plasma Levels of Vascular Disease Risk Factors in Greenland Inuit

  1999cites this paper
• Factor V:Q506 Mutation-Resistance to Activated Protein C (APC): Clinical Implications with Respect to Family Screening

  1998cites this paper
• Increased rate of factor V Leiden mutation in patients with cerebral venous thrombosis

  1998influential citation
• Epidemiology of Factor V Leiden: Clinical Implications

  1998cites this paper
• Screening Tests for Thrombophilic Patients: Which Tests, for Which Patient, by Whom, When, and Why?

  1998cites this paper
• The Arg506Gln mutation (FV Leiden) among a cohort of 4188 unselected Danish newborns.

  1998cites this paper
• Hypercoagulability in Venous and Arterial Thrombosis

  1997cites this paper
• Molecular Genetics of Factor V Leiden: Genetic Origins and Modern DNA-Based Detection Strategies

  1997cites this paper
• State-of-the-Art Review: Activated Protein C Resistance: Clinical Implications

  1997cites this paper
• Prevalence of factor V Leiden mutation in various populations

  1997cites this paper
• Detection of a common mutation in factor V gene responsible for resistance to activated protein C causing predisposition to thrombosis

  1997cites this paper
• allele in the 330 Japanese people in our study suggests that this allele does not have an important role in the risk of cardiovascular events in Japan.

  1997cites this paper
• A single genetic origin for a common Caucasian risk factor for venous thrombosis.

  1997cites this paper
• PIA1/A2 polymorphism of platelet glycoprotein Illa and risk of cardiovascular disease

  1997cites this paper
• Activated protein C resistance--a major risk factor for thrombosis.

  1997cites this paper
• High Prevalence of Factor V Leiden Mutation is Detected in a North to South Axis through Germany. Eine hohe Prävalenz der Faktor V Leiden Mutation verläuft in einer Nord-Südachse durch Deutschland

  1997cites this paper
• Royal College of Physicians of Edinburgh/Royal College of Obstetricians and Gynaecologists consensus conference on anti-D prophylaxis 7-8 April 1997.

  1997cites this paper
• Prevalence of Factor V Leiden Mutation in Non-European Populations

  1997cites this paper
• The Population Genetics of Factor V Leiden (Arg506Gln)

  1996cites this paper